Antipodes Partners’s Becton Dickinson BDX Stock Holding History

Antipodes Partners’s Portfolio BDX Stock Details BDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-517	Closed	-$118K	–	110
2025 Q1	$118K	Buy	+517	New	+$120K	﹤0.01%	71

Other funds holding BDX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Antipodes Partners's BDX Position: Q2 2025 in Review

Antipodes Partners sold out of Becton Dickinson (BDX) in Q2 2025, closing a stake of 517 shares — an estimated $118K sold.

Antipodes Partners first reported a position in BDX in Q1 2025 and held it in 1 quarter. The position peaked at $118K in Q1 2025. 1,516 funds tracked by Wall St. Rank hold BDX as of Q2 2025.

Antipodes Partners reported no remaining Becton Dickinson position as of Q2 2025 after selling out during the quarter.
Antipodes Partners sold 517 Becton Dickinson shares in Q2 2025, an estimated $118K.
Antipodes Partners first reported a position in Becton Dickinson in Q1 2025 and held it in 1 quarter.
Antipodes Partners's Becton Dickinson position peaked at $118K in Q1 2025.
1,516 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2025.

Based on Antipodes Partners's 13F filing for Q2 2025, filed 5 Aug 2025.